BGM
ACET icon

Burkehill Global Management’s Adicet Bio ACET Stock Holding History

Burkehill Global Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$540K Hold
62,500
– – 0.02% 166
2026
Q1 		$426K Hold
62,500
– – 0.02% 175
2025
Q4 		$526K Buy
+62,500
New +$691K 0.03% 157

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Burkehill Global Management's ACET Position: Q2 2026 in Review

Burkehill Global Management held its Adicet Bio (ACET) position steady in Q2 2026 at 62,500 shares worth $540K. The position accounts for 0.02% of the portfolio, ranked #166.

Burkehill Global Management first reported a position in ACET in Q4 2025 and has held it in 3 quarters since. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • Burkehill Global Management held 62,500 shares of Adicet Bio worth $540K as of Q2 2026.
  • Burkehill Global Management left its Adicet Bio share count unchanged in Q2 2026.
  • Adicet Bio made up 0.02% of Burkehill Global Management's portfolio in Q2 2026, its #166 holding.
  • Burkehill Global Management first reported a position in Adicet Bio in Q4 2025 and has held it in 3 quarters since.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Burkehill Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.